{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:14:55Z","timestamp":1790720095112,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cadherin-16 (CDH16) plays a role in the embryonal development in kidney and thyroid. Downregulation of CDH16 RNA was found in papillary carcinomas of the thyroid. To determine the expression of CDH16 in tumors and to assess the diagnostic utility a tissue microarray containing 15,584 samples from 152 different tumor types as well as 608 samples of 76 different normal tissue types was analyzed. A membranous CDH16 immunostaining was predominantly seen in thyroid, kidney, cauda epididymis, and mesonephric remnants. In the thyroid, CDH16 staining was seen in 100% of normal samples, 86% of follicular adenomas, 60% of follicular carcinomas, but only 7% of papillary carcinomas (p\u2009&lt;\u20090.0001). CDH16 positivity was frequent in nephrogenic adenomas (100%), oncocytomas (98%), chromophobe (97%), clear cell (85%), and papillary (76%) renal cell carcinomas (RCCs), various subtypes of carcinoma of the ovary (16\u201356%), various subtyped of carcinomas of the uterus (18\u201340%), as well as in various subtypes of neuroendocrine neoplasms (4\u201326%). Nineteen further tumor entities showed a weak to moderate CDH16 staining in up to 8% of cases. Our data suggest CDH16 as a potential diagnostic marker\u2014as a part of a panel\u2014for the identification of papillary carcinomas of the thyroid, nephrogenic adenomas, and the distinction of renal cell tumors from other neoplasms.<\/jats:p>","DOI":"10.1038\/s41598-023-39945-2","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T09:02:38Z","timestamp":1691571758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid"],"prefix":"10.1038","volume":"13","author":[{"given":"Maximilian","family":"Lennartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Csom\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Chirico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gorbokon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Menz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"B\u00fcscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"H\u00f6flmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bernreuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas C.","family":"Blessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lebok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Burandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Krech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Luebke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Khalid","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Al-Dayel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawla S.","family":"Al-Kuraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hinsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"39945_CR1","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/sj.bjc.6602597","volume":"92","author":"C Thedieck","year":"2005","unstructured":"Thedieck, C. et al. Expression of Ksp-cadherin during kidney development and in renal cell carcinoma. Br. J. Cancer 92, 2010\u20132017. https:\/\/doi.org\/10.1038\/sj.bjc.6602597 (2005).","journal-title":"Br. J. Cancer"},{"key":"39945_CR2","doi-asserted-by":"publisher","first-page":"F146","DOI":"10.1152\/ajprenal.1999.277.1.F146","volume":"277","author":"RB Thomson","year":"1999","unstructured":"Thomson, R. B. & Aronson, P. S. Immunolocalization of Ksp-cadherin in the adult and developing rabbit kidney. Am. J. Physiol. 277, F146-156. https:\/\/doi.org\/10.1152\/ajprenal.1999.277.1.F146 (1999).","journal-title":"Am. J. Physiol."},{"key":"39945_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1242\/jcs.184291","volume":"130","author":"P Koumarianou","year":"2017","unstructured":"Koumarianou, P., Gomez-Lopez, G. & Santisteban, P. Pax8 controls thyroid follicular polarity through cadherin-16. J. Cell Sci. 130, 219\u2013231. https:\/\/doi.org\/10.1242\/jcs.184291 (2017).","journal-title":"J. Cell Sci."},{"key":"39945_CR4","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.2147\/CMAR.S229631","volume":"11","author":"P Li","year":"2019","unstructured":"Li, P. et al. Downregulation of CDH16 in papillary thyroid cancer and its potential molecular mechanism analysed by qRT-PCR, TCGA and in silico analysis. Cancer Manag. Res. 11, 10719\u201310729. https:\/\/doi.org\/10.2147\/CMAR.S229631 (2019).","journal-title":"Cancer Manag. Res."},{"key":"39945_CR5","doi-asserted-by":"publisher","first-page":"D752","DOI":"10.1093\/nar\/gky1099","volume":"47","author":"M Lizio","year":"2019","unstructured":"Lizio, M. et al. Update of the FANTOM web resource: Expansion to provide additional transcriptome atlases. Nucleic Acids Res. 47, D752\u2013D758. https:\/\/doi.org\/10.1093\/nar\/gky1099 (2019).","journal-title":"Nucleic Acids Res."},{"key":"39945_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3321","author":"PJ Thul","year":"2017","unstructured":"Thul, P. J. et al. A subcellular map of the human proteome. Science https:\/\/doi.org\/10.1126\/science.aal3321 (2017).","journal-title":"Science"},{"key":"39945_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","volume":"16","author":"M Lizio","year":"2015","unstructured":"Lizio, M. et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 16, 22. https:\/\/doi.org\/10.1186\/s13059-014-0560-6 (2015).","journal-title":"Genome Biol."},{"key":"39945_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585. https:\/\/doi.org\/10.1038\/ng.2653 (2013).","journal-title":"Nat. Genet."},{"key":"39945_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1210\/en.2011-1572","volume":"153","author":"G Cali","year":"2012","unstructured":"Cali, G. et al. CDH16\/Ksp-cadherin is expressed in the developing thyroid gland and is strongly down-regulated in thyroid carcinomas. Endocrinology 153, 522\u2013534. https:\/\/doi.org\/10.1210\/en.2011-1572 (2012).","journal-title":"Endocrinology"},{"key":"39945_CR10","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/PAS.0b013e318058818c","volume":"31","author":"A Kuehn","year":"2007","unstructured":"Kuehn, A. et al. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: Diagnostic and histogenetic implications. Am. J. Surg. Pathol. 31, 1528\u20131533. https:\/\/doi.org\/10.1097\/PAS.0b013e318058818c (2007).","journal-title":"Am. J. Surg. Pathol."},{"key":"39945_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1309\/JFE2-B57Y-QFPW-PL10","volume":"126","author":"BP Adley","year":"2006","unstructured":"Adley, B. P. et al. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am. J. Clin. Pathol. 126, 79\u201385. https:\/\/doi.org\/10.1309\/JFE2-B57Y-QFPW-PL10 (2006).","journal-title":"Am. J. Clin. Pathol."},{"key":"39945_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humpath.2004.09.011","volume":"36","author":"PR Mazal","year":"2005","unstructured":"Mazal, P. R. et al. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum. Pathol. 36, 22\u201328. https:\/\/doi.org\/10.1016\/j.humpath.2004.09.011 (2005).","journal-title":"Hum. Pathol."},{"key":"39945_CR13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/modpathol.3800373","volume":"18","author":"SS Shen","year":"2005","unstructured":"Shen, S. S., Krishna, B., Chirala, R., Amato, R. J. & Truong, L. D. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod. Pathol. 18, 933\u2013940. https:\/\/doi.org\/10.1038\/modpathol.3800373 (2005).","journal-title":"Mod. Pathol."},{"key":"39945_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/PAI.0b013e31823fecd3","volume":"20","author":"S Yasir","year":"2012","unstructured":"Yasir, S. et al. CD10+ and CK7\/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Appl. Immunohistochem. Mol. Morphol. 20, 454\u2013461. https:\/\/doi.org\/10.1097\/PAI.0b013e31823fecd3 (2012).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"39945_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/pin.12254","volume":"65","author":"Y Iribe","year":"2015","unstructured":"Iribe, Y. et al. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dube syndrome. Pathol. Int. 65, 126\u2013132. https:\/\/doi.org\/10.1111\/pin.12254 (2015).","journal-title":"Pathol. Int."},{"key":"39945_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prp.2016.04.009","volume":"213","author":"G Han","year":"2017","unstructured":"Han, G. et al. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases. Pathol. Res. Pract. 213, 1\u20136. https:\/\/doi.org\/10.1016\/j.prp.2016.04.009 (2017).","journal-title":"Pathol. Res. Pract."},{"key":"39945_CR17","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/modpathol.2012.202","volume":"26","author":"JP Gaut","year":"2013","unstructured":"Gaut, J. P., Crimmins, D. L., Lockwood, C. M., McQuillan, J. J. & Ladenson, J. H. Expression of the Na+\/K+-transporting ATPase gamma subunit FXYD2 in renal tumors. Mod. Pathol. 26, 716\u2013724. https:\/\/doi.org\/10.1038\/modpathol.2012.202 (2013).","journal-title":"Mod. Pathol."},{"key":"39945_CR18","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.18632\/oncotarget.27632","volume":"11","author":"JD Bloomstein","year":"2020","unstructured":"Bloomstein, J. D. et al. Validated limited gene predictor for cervical cancer lymph node metastases. Oncotarget 11, 2302\u20132309. https:\/\/doi.org\/10.18632\/oncotarget.27632 (2020).","journal-title":"Oncotarget"},{"key":"39945_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1055\/s-0035-1569289","volume":"48","author":"WB Li","year":"2016","unstructured":"Li, W. B. et al. Identification of genes associated with papillary thyroid carcinoma (PTC) for diagnosis by integrated analysis. Horm. Metab. Res. 48, 226\u2013231. https:\/\/doi.org\/10.1055\/s-0035-1569289 (2016).","journal-title":"Horm. Metab. Res."},{"key":"39945_CR20","doi-asserted-by":"publisher","first-page":"e7632","DOI":"10.1371\/journal.pone.0007632","volume":"4","author":"JF Fontaine","year":"2009","unstructured":"Fontaine, J. F. et al. Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers. PLoS One 4, e7632. https:\/\/doi.org\/10.1371\/journal.pone.0007632 (2009).","journal-title":"PLoS One"},{"key":"39945_CR21","doi-asserted-by":"publisher","first-page":"151793","DOI":"10.1016\/j.anndiagpath.2021.151793","volume":"54","author":"S Steurer","year":"2021","unstructured":"Steurer, S. et al. Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin. Ann. Diagn. Pathol. 54, 151793. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151793 (2021).","journal-title":"Ann. Diagn. Pathol."},{"key":"39945_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/PAI.0b013e3181c61cdd","volume":"18","author":"M Wallander","year":"2010","unstructured":"Wallander, M. et al. Follicular variant of papillary carcinoma: Reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts. Appl. Immunohistochem. Mol. Morphol. 18, 231\u2013235. https:\/\/doi.org\/10.1097\/PAI.0b013e3181c61cdd (2010).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"39945_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1159\/000326448","volume":"48","author":"S Gupta","year":"2004","unstructured":"Gupta, S., Sodhani, P., Jain, S. & Kumar, N. Morphologic spectrum of papillary carcinoma of the thyroid: Role of cytology in identifying the variants. Acta Cytol. 48, 795\u2013800. https:\/\/doi.org\/10.1159\/000326448 (2004).","journal-title":"Acta Cytol."},{"key":"39945_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/s0046-8177(03)00403-9","volume":"34","author":"B Franc","year":"2003","unstructured":"Franc, B. et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum. Pathol. 34, 1092\u20131100. https:\/\/doi.org\/10.1016\/s0046-8177(03)00403-9 (2003).","journal-title":"Hum. Pathol."},{"key":"39945_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1699-0463.1978.tb02073.x","volume":"86A","author":"E Saxen","year":"1978","unstructured":"Saxen, E., Franssila, K., Bjarnason, O., Normann, T. & Ringertz, N. Observer variation in histologic classification of thyroid cancer. Acta Pathol. Microbiol. Scand. A 86A, 483\u2013486. https:\/\/doi.org\/10.1111\/j.1699-0463.1978.tb02073.x (1978).","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"key":"39945_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/cncr.11175","volume":"97","author":"J Zidan","year":"2003","unstructured":"Zidan, J. et al. Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival. Cancer 97, 1181\u20131185. https:\/\/doi.org\/10.1002\/cncr.11175 (2003).","journal-title":"Cancer"},{"key":"39945_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1097\/01.pas.0000135519.34847.f6","volume":"28","author":"RV Lloyd","year":"2004","unstructured":"Lloyd, R. V. et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am. J. Surg. Pathol. 28, 1336\u20131340. https:\/\/doi.org\/10.1097\/01.pas.0000135519.34847.f6 (2004).","journal-title":"Am. J. Surg. Pathol."},{"key":"39945_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5455\/aim.2019.27.114-118","volume":"27","author":"M Sulejmanovic","year":"2019","unstructured":"Sulejmanovic, M., Cickusic, A. J. & Salkic, S. The value of fine-needle aspiration biopsy (FNAB) in differential diagnosis of scintigraphic cold thyroid nodule. Acta Inform. Med. 27, 114\u2013118. https:\/\/doi.org\/10.5455\/aim.2019.27.114-118 (2019).","journal-title":"Acta Inform. Med."},{"issue":"Suppl 1","key":"39945_CR29","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.1002\/dc.21566","volume":"40","author":"JL Seningen","year":"2012","unstructured":"Seningen, J. L., Nassar, A. & Henry, M. R. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001\u20132007: An institutional experience of 1,945 cases. Diagn. Cytopathol. 40(Suppl 1), E27-32. https:\/\/doi.org\/10.1002\/dc.21566 (2012).","journal-title":"Diagn. Cytopathol."},{"key":"39945_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/cncy.21454","volume":"122","author":"A Proietti","year":"2014","unstructured":"Proietti, A. et al. Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas. Cancer Cytopathol. 122, 751\u2013759. https:\/\/doi.org\/10.1002\/cncy.21454 (2014).","journal-title":"Cancer Cytopathol."},{"key":"39945_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/dc.22976","volume":"41","author":"VY Jo","year":"2013","unstructured":"Jo, V. Y., Renshaw, A. A. & Krane, J. F. Relative sensitivity of thyroid fine-needle aspiration by tumor type and size. Diagn. Cytopathol. 41, 871\u2013875. https:\/\/doi.org\/10.1002\/dc.22976 (2013).","journal-title":"Diagn. Cytopathol."},{"key":"39945_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/lary.23861","volume":"123","author":"R Mehanna","year":"2013","unstructured":"Mehanna, R. et al. False negatives in thyroid cytology: Impact of large nodule size and follicular variant of papillary carcinoma. Laryngoscope 123, 1305\u20131309. https:\/\/doi.org\/10.1002\/lary.23861 (2013).","journal-title":"Laryngoscope"},{"key":"39945_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pbc.24051","volume":"59","author":"A Redlich","year":"2012","unstructured":"Redlich, A. et al. Sensitivity of fine-needle biopsy in detecting pediatric differentiated thyroid carcinoma. Pediatr. Blood Cancer 59, 233\u2013237. https:\/\/doi.org\/10.1002\/pbc.24051 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"39945_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/thy.2011.0021","volume":"21","author":"AJ Adeniran","year":"2011","unstructured":"Adeniran, A. J. et al. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: A prospective study. Thyroid 21, 717\u2013723. https:\/\/doi.org\/10.1089\/thy.2011.0021 (2011).","journal-title":"Thyroid"},{"key":"39945_CR35","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s00268-010-0391-x","volume":"34","author":"AE Bargren","year":"2010","unstructured":"Bargren, A. E. et al. Diagnostic utility of fine-needle aspiration cytology in pediatric differentiated thyroid cancer. World J. Surg. 34, 1254\u20131260. https:\/\/doi.org\/10.1007\/s00268-010-0391-x (2010).","journal-title":"World J. Surg."},{"key":"39945_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000325977","volume":"50","author":"C de la Serna Saravia","year":"2006","unstructured":"de la Serna Saravia, C., Cuellar, F., Saravio Day, E. & Harach, H. R. Accuracy of aspiration cytology in thyroid cancer: A study in 1 institution. Acta Cytol. 50, 384\u2013387. https:\/\/doi.org\/10.1159\/000325977 (2006).","journal-title":"Acta Cytol."},{"key":"39945_CR37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s00268-004-6953-z","volume":"28","author":"JC Furlan","year":"2004","unstructured":"Furlan, J. C., Bedard, Y. C. & Rosen, I. B. Role of fine-needle aspiration biopsy and frozen section in the management of papillary thyroid carcinoma subtypes. World J. Surg. 28, 880\u2013885. https:\/\/doi.org\/10.1007\/s00268-004-6953-z (2004).","journal-title":"World J. Surg."},{"key":"39945_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/105072504773297885","volume":"14","author":"MW Yeh","year":"2004","unstructured":"Yeh, M. W., Demircan, O., Ituarte, P. & Clark, O. H. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 14, 207\u2013215. https:\/\/doi.org\/10.1089\/105072504773297885 (2004).","journal-title":"Thyroid"},{"key":"39945_CR39","first-page":"438","volume":"54","author":"JS Munn","year":"1988","unstructured":"Munn, J. S., Castelli, M., Prinz, R. A. & Walloch, J. L. Needle biopsy of nodular thyroid disease. Am. Surg. 54, 438\u2013443 (1988).","journal-title":"Am. Surg."},{"key":"39945_CR40","first-page":"850","volume":"29","author":"M Akerman","year":"1985","unstructured":"Akerman, M., Tennvall, J., Biorklund, A., Martensson, H. & Moller, T. Sensitivity and specificity of fine needle aspiration cytology in the diagnosis of tumors of the thyroid gland. Acta Cytol. 29, 850\u2013855 (1985).","journal-title":"Acta Cytol."},{"key":"39945_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/030089168407000313","volume":"70","author":"M Radetic","year":"1984","unstructured":"Radetic, M., Kralj, Z. & Padovan, I. Reliability of aspiration biopsy in thyroid nodes: Study of 2190 operated patients. Tumori 70, 271\u2013276 (1984).","journal-title":"Tumori"},{"key":"39945_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.humpath.2021.11.003","volume":"119","author":"CV Chen","year":"2022","unstructured":"Chen, C. V., Croom, N. A., Simko, J. P., Stohr, B. A. & Chan, E. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: Pitfalls for diagnosis. Hum. Pathol. 119, 85\u201393. https:\/\/doi.org\/10.1016\/j.humpath.2021.11.003 (2022).","journal-title":"Hum. Pathol."},{"key":"39945_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5858\/arpa.2011-0472-RA","volume":"136","author":"SS Shen","year":"2012","unstructured":"Shen, S. S., Truong, L. D., Scarpelli, M. & Lopez-Beltran, A. Role of immunohistochemistry in diagnosing renal neoplasms: When is it really useful?. Arch. Pathol. Lab. Med. 136, 410\u2013417. https:\/\/doi.org\/10.5858\/arpa.2011-0472-RA (2012).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"39945_CR44","doi-asserted-by":"publisher","first-page":"348 e341","DOI":"10.1016\/j.urolonc.2022.03.017","volume":"40","author":"M Lennartz","year":"2022","unstructured":"Lennartz, M. et al. Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16. Urol. Oncol. 40, 348 e341-348 e348. https:\/\/doi.org\/10.1016\/j.urolonc.2022.03.017 (2022).","journal-title":"Urol. Oncol."},{"key":"39945_CR45","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/PAI.0b013e3182444a4e","volume":"20","author":"JA Ortiz-Rey","year":"2012","unstructured":"Ortiz-Rey, J. A., Anton-Badiola, I., Perez-Pedrosa, A., Peteiro-Cancelo, A. & Gonzalez-Carrero, J. Nephrogenic adenoma: An immunohistochemical analysis using biotin-free methods. Appl. Immunohistochem. Mol. Morphol. 20, 386\u2013391. https:\/\/doi.org\/10.1097\/PAI.0b013e3182444a4e (2012).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"39945_CR46","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.3390\/ijms21197146","volume":"21","author":"J Courcier","year":"2020","unstructured":"Courcier, J. et al. Carbonic anhydrase IX in renal cell carcinoma, implications for disease management. Int. J. Mol. Sci. 21, 7146. https:\/\/doi.org\/10.3390\/ijms21197146 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"39945_CR47","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12253-015-9898-7","volume":"21","author":"HA Alshenawy","year":"2015","unstructured":"Alshenawy, H. A. Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features. Pathol. Oncol. Res. 21, 893\u2013899. https:\/\/doi.org\/10.1007\/s12253-015-9898-7 (2015).","journal-title":"Pathol. Oncol. Res."},{"key":"39945_CR48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.acthis.2012.10.009","volume":"115","author":"W Yu","year":"2013","unstructured":"Yu, W. et al. Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: New diagnostic and prognostic information. Acta Histochem. 115, 452\u2013459. https:\/\/doi.org\/10.1016\/j.acthis.2012.10.009 (2013).","journal-title":"Acta Histochem."},{"key":"39945_CR49","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.3892\/ol.2017.6949","volume":"14","author":"HJ Chai","year":"2017","unstructured":"Chai, H. J. et al. PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer. Oncol. Lett. 14, 5871\u20135875. https:\/\/doi.org\/10.3892\/ol.2017.6949 (2017).","journal-title":"Oncol. Lett."},{"key":"39945_CR50","doi-asserted-by":"publisher","first-page":"32785","DOI":"10.18632\/oncotarget.9051","volume":"7","author":"LH Rodgers","year":"2016","unstructured":"Rodgers, L. H., Young, A. N. & Burdette, J. E. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Oncotarget 7, 32785\u201332795. https:\/\/doi.org\/10.18632\/oncotarget.9051 (2016).","journal-title":"Oncotarget"},{"key":"39945_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1309\/AJCPU0FION3RKKFO","volume":"137","author":"L Zhao","year":"2012","unstructured":"Zhao, L., Guo, M., Sneige, N. & Gong, Y. Value of PAX8 and WT1 immunostaining in confirming the ovarian origin of metastatic carcinoma in serous effusion specimens. Am. J. Clin. Pathol. 137, 304\u2013309. https:\/\/doi.org\/10.1309\/AJCPU0FION3RKKFO (2012).","journal-title":"Am. J. Clin. Pathol."},{"key":"39945_CR52","doi-asserted-by":"publisher","first-page":"e0156658","DOI":"10.1371\/journal.pone.0156658","volume":"11","author":"F Rosignolo","year":"2016","unstructured":"Rosignolo, F. et al. Expression of PAX8 target genes in papillary thyroid carcinoma. PLoS One 11, e0156658. https:\/\/doi.org\/10.1371\/journal.pone.0156658 (2016).","journal-title":"PLoS One"},{"key":"39945_CR53","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1507\/endocrj.EJ15-0226","volume":"62","author":"A Suzuki","year":"2015","unstructured":"Suzuki, A. et al. Diagnostic significance of PAX8 in thyroid squamous cell carcinoma. Endocr. J. 62, 991\u2013995. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0226 (2015).","journal-title":"Endocr. J."},{"key":"39945_CR54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/modpathol.3801002","volume":"21","author":"D Nonaka","year":"2008","unstructured":"Nonaka, D., Tang, Y., Chiriboga, L., Rivera, M. & Ghossein, R. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod. Pathol. 21, 192\u2013200. https:\/\/doi.org\/10.1038\/modpathol.3801002 (2008).","journal-title":"Mod. Pathol."},{"key":"39945_CR55","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/PAI.0000000000000830","volume":"28","author":"H Lu","year":"2020","unstructured":"Lu, H., Allende, D., Liu, X. & Zhang, Y. Lymphoid enhancer binding factor 1 (LEF1) and paired box gene 8 (PAX8): A limited immunohistochemistry panel to distinguish solid pseudopapillary neoplasms and pancreatic neuroendocrine tumors. Appl. Immunohistochem. Mol. Morphol. 28, 776\u2013780. https:\/\/doi.org\/10.1097\/PAI.0000000000000830 (2020).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"39945_CR56","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/PAS.0b013e318218df97","volume":"35","author":"YB Chen","year":"2011","unstructured":"Chen, Y. B., Fine, S. W. & Epstein, J. I. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: Findings at radical prostatectomy. Am. J. Surg. Pathol. 35, 1054\u20131061. https:\/\/doi.org\/10.1097\/PAS.0b013e318218df97 (2011).","journal-title":"Am. J. Surg. Pathol."},{"key":"39945_CR57","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/PAS.0b013e3181e5e03e","volume":"34","author":"AD Corben","year":"2010","unstructured":"Corben, A. D., Nehhozina, T., Garg, K., Vallejo, C. E. & Brogi, E. Endosalpingiosis in axillary lymph nodes: A possible pitfall in the staging of patients with breast carcinoma. Am. J. Surg. Pathol. 34, 1211\u20131216. https:\/\/doi.org\/10.1097\/PAS.0b013e3181e5e03e (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"39945_CR58","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/PAS.0b013e31816b1020","volume":"32","author":"GX Tong","year":"2008","unstructured":"Tong, G. X. et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: Evidence of related histogenesis?. Am. J. Surg. Pathol. 32, 1380\u20131387. https:\/\/doi.org\/10.1097\/PAS.0b013e31816b1020 (2008).","journal-title":"Am. J. Surg. Pathol."},{"issue":"531","key":"39945_CR59","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1016\/j.urolonc.2018.08.015","volume":"36","author":"F Buscheck","year":"2018","unstructured":"Buscheck, F. et al. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma. Urol. Oncol. 36(531), e519-531 e525. https:\/\/doi.org\/10.1016\/j.urolonc.2018.08.015 (2018).","journal-title":"Urol. Oncol."},{"key":"39945_CR60","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1186\/s12885-019-6353-2","volume":"19","author":"W Alves","year":"2019","unstructured":"Alves, W. et al. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy. BMC Cancer 19, 1173. https:\/\/doi.org\/10.1186\/s12885-019-6353-2 (2019).","journal-title":"BMC Cancer"},{"key":"39945_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/ijms20020375","volume":"20","author":"AW Eckert","year":"2019","unstructured":"Eckert, A. W. et al. Investigation of the prognostic role of carbonic anhydrase 9 (CAIX) of the cellular mRNA\/protein level or soluble CAIX protein in patients with oral squamous cell carcinoma. Int. J. Mol. Sci. 20, 375. https:\/\/doi.org\/10.3390\/ijms20020375 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"39945_CR62","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s12253-017-0284-5","volume":"24","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. Overexpression of FZD1 and CAIX are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Pathol. Oncol. Res. 24, 899\u2013906. https:\/\/doi.org\/10.1007\/s12253-017-0284-5 (2018).","journal-title":"Pathol. Oncol. Res."},{"key":"39945_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1615\/JEnvironPatholToxicolOncol.2016016099","volume":"35","author":"S Senol","year":"2016","unstructured":"Senol, S. et al. Gastric adenocarcinoma biomarker expression profiles and their prognostic value. J. Environ. Pathol. Toxicol. Oncol. 35, 207\u2013222. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2016016099 (2016).","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"39945_CR64","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.14670\/HH-26.1279","volume":"26","author":"C Pinheiro","year":"2011","unstructured":"Pinheiro, C. et al. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol. Histopathol. 26, 1279\u20131286. https:\/\/doi.org\/10.14670\/HH-26.1279 (2011).","journal-title":"Histol. Histopathol."},{"key":"39945_CR65","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3892\/ijo.2017.4098","volume":"51","author":"S Hyuga","year":"2017","unstructured":"Hyuga, S. et al. Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelialmesenchymal transition in hepatocellular carcinoma. Int. J. Oncol. 51, 1179\u20131190. https:\/\/doi.org\/10.3892\/ijo.2017.4098 (2017).","journal-title":"Int. J. Oncol."},{"key":"39945_CR66","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1746-1596-8-74","volume":"8","author":"S Meguro","year":"2013","unstructured":"Meguro, S., Yasuda, M., Shimizu, M., Kurosaki, A. & Fujiwara, K. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: A case report and review of the literature. Diagn. Pathol. 8, 74. https:\/\/doi.org\/10.1186\/1746-1596-8-74 (2013).","journal-title":"Diagn. Pathol."},{"key":"39945_CR67","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844\u2013847. https:\/\/doi.org\/10.1038\/nm0798-844 (1998).","journal-title":"Nat. Med."},{"key":"39945_CR68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4939-3204-7_3","volume":"1381","author":"AM Dancau","year":"2016","unstructured":"Dancau, A. M., Simon, R., Mirlacher, M. & Sauter, G. Tissue microarrays. Methods Mol. Biol. 1381, 53\u201365. https:\/\/doi.org\/10.1007\/978-1-4939-3204-7_3 (2016).","journal-title":"Methods Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39945-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T14:08:45Z","timestamp":1700402925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39945-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39945"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39945-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CDH16 antibody clone MSVA-516R was provided by MS Validated Antibodies GmbH (owned by a family member of Prof. Dr. Guido Sauter). All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12917"}}